Substantiation Committee
Substantiation Committee
Chair:
M. Gerassopoulos (Sanofi-Aventis S.A.), Vice President of SFEE
Working Group of Innovative Medicines
Coordinator: A. Angeli, Communication & Institutional Relations Director, Sanofi-Aventis
IMS Working Group
Coordinator: N. Ragoussis, Commercial Relations & Supply Chain Manager, Merck Sharp & Dohme
